Skip to content
Disclosery

EXANE DERIVATIVES: SE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on SE, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 5,347 SE shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 5,347 shares
    Change vs previous 13F -771 shares

    0.21% of the 13F portfolio, value $357,434.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 6,118 shares
    Change vs previous 13F +737 shares

    0.21% of the 13F portfolio, value $732,830.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 5,381 shares
    Change vs previous 13F +2,123 shares

    0.29% of the 13F portfolio, value $1,203,740.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 3,258 shares
    Change vs previous 13F -245 shares

    0.26% of the 13F portfolio, value $1,038,385.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 3,503 shares
    Change vs previous 13F -6 shares

    0.23% of the 13F portfolio, value $984,110.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 3,509 shares
    Change vs previous 13F -2,198 shares

    0.24% of the 13F portfolio, value $783,279.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 5,707 shares
    Change vs previous 13F +830 shares

    0.34% of the 13F portfolio, value $1,135,926.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 4,877 shares
    Change vs previous 13F not available

    0.24% of the 13F portfolio, value $751,212.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).